Smith & Nephew (LON:SN) Stock Rating Reaffirmed by Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Smith & Nephew (LON:SN) in a report published on Thursday, Marketbeat Ratings reports. They currently have a GBX 1,450 ($18.21) target price on the stock.

Other equities research analysts have also recently issued research reports about the company. JPMorgan Chase & Co. reaffirmed an overweight rating and issued a GBX 1,300 ($16.33) price target on shares of Smith & Nephew in a report on Thursday, April 18th. Barclays reaffirmed an equal weight rating and issued a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a research note on Friday, February 9th. Finally, Royal Bank of Canada reissued an outperform rating and set a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a research report on Friday, April 5th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Smith & Nephew presently has a consensus rating of Moderate Buy and a consensus target price of GBX 1,346.20 ($16.91).

Smith & Nephew Stock Up 1.1 %

SN stock opened at GBX 996.80 ($12.52) on Thursday. The company has a current ratio of 1.77, a quick ratio of 0.84 and a debt-to-equity ratio of 59.11. The firm has a 50-day moving average of GBX 1,018.36 and a two-hundred day moving average of GBX 1,035.12. Smith & Nephew has a 12 month low of GBX 887 ($11.14) and a 12 month high of GBX 1,316.75 ($16.54). The company has a market cap of £8.72 billion, a price-to-earnings ratio of 4,153.33, a PEG ratio of 0.46 and a beta of 0.51.

Smith & Nephew Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be given a $0.23 dividend. This represents a yield of 1.62%. This is a positive change from Smith & Nephew’s previous dividend of $0.14. The ex-dividend date is Thursday, March 28th. Smith & Nephew’s dividend payout ratio is presently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.